Urgent Health Care P.c. | |
212 N 3rd St Suite B Mccall ID 83638-4414 | |
(208) 315-4390 | |
Not Available |
Full Name | Urgent Health Care P.c. |
---|---|
Speciality | General Practice |
Location | 212 N 3rd St, Mccall, Idaho |
Authorized Official Name and Position | John Alan Holley (MEDICAL DIRECTOR) |
Authorized Official Contact | 2083154390 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Urgent Health Care P.c. Po Box 2603 Mccall ID 83638-2603 Ph: (208) 315-4390 | Urgent Health Care P.c. 212 N 3rd St Suite B Mccall ID 83638-4414 Ph: (208) 315-4390 |
NPI Number | 1548504053 |
---|---|
Provider Enumeration Date | 11/21/2012 |
Last Update Date | 11/21/2012 |
Identifier | Type | State | Issuer |
---|---|---|---|
1548504053 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | M-11371 (Idaho) | Primary |
News Archive
Spectral Diagnostics Inc., a Phase III company developing the first theranostic treatment for severe sepsis and septic shock, and Medwell Capital Corp., today jointly announced a non-brokered agreement whereby Medwell and a consortium of buyers purchased in private transactions 12,449,501 common shares and 962,500 common share purchase warrants of Spectral from GrowthWorks Canadian Fund Ltd., representing 15.6% of the issued and outstanding shares.
Published in The Lancet, the study explores if the Oxford-AstraZeneca vaccine works well in protecting against the B.1.1.7 variant, otherwise known as the U.K. variant.
Health care continues to play a major role this political season. News outlets look at the parties' differences on spending, Sen. Baucus' early reelection calculations and a protest against Rep. Steve King.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval for the use of ENTEREGĀ® (alvimopan) to accelerate GI recovery following any surgery that includes a bowel resection with primary anastomosis; expanded from the current indication in patients requiring surgery for colorectal disease.
› Verified 8 days ago
St Lukes Payette Lakes Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 211 Forest St, Mccall, ID 83638 Phone: 208-634-2225 | |
Payette Lakes Medical Clinic, Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 211 Forest Street, Mccall, ID 83638 Phone: 208-634-2225 Fax: 208-634-7212 | |
Jennifer Paulson Np, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 201 E Park St, Mccall, ID 83638 Phone: 208-607-3738 Fax: 208-369-9274 | |
St Luke's Payette Lakes Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 211 Forest St, Mccall, ID 83638 Phone: 208-634-2225 |